通讯作者: 肖 玮, 252465965@qq.com

DOI：10.12201/bmr.202506.00039

To explore the mechanism of oxidative stress and metabolic imbalance in COPD combined with type 2 diabetes from Qi-blood-body fluid theory

• 摘要：慢性阻塞性肺疾病(Chronic obstructive pulmonary disease, COPD)及2型糖尿病(Type 2 diabete mellitus,T2DM)作为常见的慢性疾病,二者并存时病情复杂且预后不佳。本文基于中医气血津液理论,深入探讨其与慢阻肺合并糖尿病氧化应激及代谢失衡之间的内在关联机制,旨在为中西医结合防治该复杂病症提供新思路,整合现代医学研究成果与传统中医智慧,挖掘潜在治疗靶点。本综述从中医气血津液理论出发,深入剖析其与慢阻肺合并糖尿病氧化应激、代谢失衡之间的关联,结合现代医学研究成果,探寻中西医结合防治该病症的理论依据,以期为临床治疗提供新思路。

  关键词： 气血津液; 慢阻肺合并2型糖尿病; 氧化应激; 代谢失衡

   

  Abstract: : Chronic obstructive pulmonary disease (COPD) and Type 2 diabete mellitus (T2DM), both common chronic diseases, are complicated and have a poor prognosis. Based on the theory of Qi-blood-body fluid in traditional Chinese medicine, this paper explores the internal correlation mechanism between QI-blood-body fluid and COPD combined with diabetes oxidative stress and metabolic imbalance, aiming to provide new ideas for the prevention and treatment of this complex disease by integrating traditional Chinese medicine and Western medicine, integrating modern medical research results with traditional Chinese medicine wisdom, and exploring potential therapeutic targets. Based on the theory of Qi-blood-body fluid in traditional Chinese medicine, this review deeply analyzes the relationship between QI-blood-body fluid theory and oxidative stress and metabolic imbalance of COPD complicated with diabetes mellitus. Combined with modern medical research results, this review explores the theoretical basis for the prevention and treatment of this disease by combining traditional Chinese and Western medicine, in order to provide new ideas for clinical treatment.

  Key words: : Qi-blood-body fluid theory; COPD combined with type 2 diabetes mellitus; Oxidative stress; Metabolic imbalance

  提交时间：2025-06-17

  版权声明：作者本人独立拥有该论文的版权，预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
• html

• 图表

• 郑鑫, 常阳, 吴道雄, 李倩倩, 冯茜, 王娓娓△. Nrf2在氧化应激所致动脉粥样硬化中的研究进展. 2025. doi: 10.12201/bmr.202503.00016

  李瑞瑶, 许婧怡, 戴浩宇, 孙慧文, 鲍瀛, 华履春, 吴天星. 基于深度置信网络的2型糖尿病微血管并发症预测. 2024. doi: 10.12201/bmr.202404.00021

  郑洁, 张真稳. SGLT2抑制剂对代谢综合征各组分的影响. 2025. doi: 10.12201/bmr.202503.00002

  芮晨, 陈玥琪, 李金斌, 张胜发. 人工智能在基层2型糖尿病健康管理中的应用进展与趋势. 2025. doi: 10.12201/bmr.202506.00072

  王涛. 门诊老年2型糖尿病患者低血糖的危险因素分析. 2024. doi: 10.12201/bmr.202412.00069

  陈家祈, 王丽, 朴春丽. 玉液汤联合二甲双胍治疗2型糖尿病Meta分析. 2024. doi: 10.12201/bmr.202407.00066

  胡燕芳. 血清CXCL14水平与2型糖尿病患者颈动脉粥样硬化斑块的关系. 2025. doi: 10.12201/bmr.202506.00073

  王一凡, 石超君, 马安宁. Ⅱ型糖尿病并发动脉粥样硬化风险预测模型比较. 2024. doi: 10.12201/bmr.202404.00007

  马小言, 杨鹏, 郭颖, 付滨. Klotho蛋白的抗氧化应激与年龄相关性眼病. 2025. doi: 10.12201/bmr.202501.00021

  梁登耀, 刘师伟. NLR、PLR对2型糖尿病肾病的预测价值. 2024. doi: 10.12201/bmr.202408.00066

• 序号	提交日期	编号	操作
  1	2025-05-15	bmr.202506.00039V1	下载

• 公开评论  匿名评论  仅发给作者 提交评论